Ani Pharmaceuticals Inc (ANIP)

EBITDA Margin

26.15%

TTM · Period ending:

ANIP logo

ANIP EBITDA Margin

Latest reported26.15%
ANIP TTM EBITDA Margin (-6083.16% → 26.15%)
High-resolution chart · PNG

ANIP ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Ani Pharmaceuticals Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-6,083.1639%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.